Sivia Capital Partners, LLC Savara Inc Transaction History
Sivia Capital Partners, LLC
- $334 Billion
- Q2 2025
A detailed history of Sivia Capital Partners, LLC transactions in Savara Inc stock. As of the latest transaction made, Sivia Capital Partners, LLC holds 41,500 shares of SVRA stock, worth $97,110. This represents 0.03% of its overall portfolio holdings.
Number of Shares
41,500
Previous 38,041
9.09%
Holding current value
$97,110
Previous $105 Million
10.21%
% of portfolio
0.03%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding SVRA
# of Institutions
142Shares Held
162MCall Options Held
54.8KPut Options Held
4.1K-
Nea Management Company, LLC Timonium, MD24.5MShares$57.3 Million6.43% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA17.6MShares$41.2 Million16.36% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$28.9 Million8.25% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA11.5MShares$26.8 Million2.0% of portfolio
-
Vestal Point Capital, LP New York, NY11MShares$25.7 Million2.18% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $267M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.